Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
See our copper peptide troubleshooting guide for addressing problems
The FDA warns that both CJC-1295 and ipamorelin carry risks of immunogenicity (triggering immune responses) and cardiovascular effects, including "increased heart rate and systemic vasodilatory reaction." One clinical trial of CJC-1295 was discontinued following a participants death, though the attending physician believed the event was "unrelated to treatment." Neither CJC-1295 nor ipamorelin is FDA-approved
Were writing the instruction manual ourselves
Ipamorelin Vials (10 mg) A 10 mg vial yields about 50 days of dosing at 200 mcg/day
Perovic D et al
All have one thing in common: the standard treatment for Lyme disease fails a significant number of patients each year
US$ 24.05
US$ 26.53
US$ 29.47
US$ 27.61
US$ 21.99
US$ 22.27
US$ 26.46
US$ 24.36
